VasQ and A
The FDA has approved VasQ, a new device to reduce fistula failure, for a 2-year clinical trial with 129 patients. The device keeps fistulas from growing too large by providing an external support.
Read the full article » | Posted 08/17/2017
- When Pigs Fly… Posted 09/15/2017
- Home Dialyzors United Helps Guide the Kidney Project Posted 09/15/2017
- DIY Dialysis? Posted 08/17/2017
- Transitioning Home Posted 07/14/2017